RxDoctor Payments Data

Emily Han

Gerontology · Baltimore, MDNPI 1548868367

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Amgen at 25.5% of the total. Reporting peaked in 2022 at $1,712 and has fallen 86.6% since, to $229 in 2025. Among gerontology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,996in general payments, 2019–2025

Across 137 payments — averaging $21.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$763
  • AbbVie$623
  • UCB, Inc.$515
  • Johnson & Johnson$418
  • Radius Health, Inc.$139
  • Aurinia Pharma U.S., Inc.$95
  • plus $443 from 9 others

What the payments were for

  • Food & beverage$2,90297%
  • Education$943%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,996 in reported general payments places this provider in the 90th percentile of 108 gerontology providers in Maryland.

See all gerontology providers in Maryland

Medicare billing

Part B allowed, 2024
$12,029
Medicare patients
84
Services billed
158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxychloroquine Sulfate50$2,589
MethotrexateMethotrexate Sodium28$1,186
Gabapentin22$270
Duloxetine Hcl19$166
Oxycodone Hcl18$49
Oxybutynin Chloride13$39

Paid to pharmacies, not to this prescriber.

Other gerontology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →